申请人:Iterum Therapeutics International Limited
公开号:US11478428B2
公开(公告)日:2022-10-25
The present disclosure relates to bilayer tablets comprising a second layer comprising a β-lactam compound or a pharmaceutically acceptable salt thereof; and a first layer comprising probenecid or a pharmaceutically acceptable salt thereof. The present disclosure also relates to methods of treating or preventing a disease using the bilayer tablets.
本公开涉及双层片剂,其第二层包括β-内酰胺化合物或其药学上可接受的盐;第一层包括丙磺舒或其药学上可接受的盐。本公开还涉及使用双层片剂治疗或预防疾病的方法。